Phase III randomized study of elective nodal irradiation plus erlotinib combined with chemotherapy for esophageal squamous cell carcinoma.

Shi Xiu Wu,Honglei Luo,L. Wang,Xuebang Zhang,Bing Xia,Congying Xie,Ming Chen,Conghua Xie,Xiuhua Bian,Wei Hu,Anping Zheng,Jiancheng Li,Duojie Li,Ruifei Xie,Gang Li

Phase III randomized study of elective nodal irradiation plus erlotinib combined with chemotherapy for esophageal squamous cell carcinoma.

2016

Shi Xiu Wu
Honglei Luo
L. Wang
Xuebang Zhang
Bing Xia
Congying Xie
Ming Chen
Conghua Xie
Xiuhua Bian
Wei Hu
Anping Zheng
Jiancheng Li
Duojie Li
Ruifei Xie
Gang Li

4048Background: The addition of anti-EGFR therapy to chemoradiotherpay in the treatment of unresectable esophageal squamous cell carcinoma (ESCC) is not well defined, as well as the role of electiv...

Keywords:

Carcinoma
Randomized controlled trial
NODAL
Erlotinib
Cancer research
Pathology
Medicine
Chemotherapy
nodal irradiation
esophageal squamous cell carcinoma
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations